News-Medical.Net on MSN
Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer
Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results